| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.085 | 0.06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |